Nicotinic acetylcholine receptor agonism: progress in the management of neuropathic pain?
Sindrup
Søren H
SH
Department of Neurology, Odense University Hospital, DK-5000 Odense C, Denmark.
D001384:Azetidines / Q000009:adverse effects / Q000627:therapeutic use*; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D000077213:Lamotrigine; D018722:Nicotinic Agonists / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D010523:Peripheral Nervous System Diseases / Q000150:complications / Q000188:drug therapy*; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use*; D011978:Receptors, Nicotinic / Q000187:drug effects*; D014227:Triazines / Q000627:therapeutic use
C109763:5-(2-azetidinylmethoxy)-2-chloropyridine; D001384:Azetidines; D018691:Excitatory Amino Acid Antagonists; D018722:Nicotinic Agonists; D011725:Pyridines; D011978:Receptors, Nicotinic; D014227:Triazines; D000077213:Lamotrigine